×
For best experience we recommend to activate Javascript in your browser.
EIF2A antibody (pSer51)
This Rabbit Polyclonal antibody specifically detects EIF2A in WB, IHC and IF. It exhibits reactivity toward Human.
Quick Overview for EIF2A antibody (pSer51) (ABIN2139736)
Target
See all EIF2A Antibodies
EIF2A
(Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))
Reactivity
All reactivities for EIF2A antibodies
Human
Host
All hosts for EIF2A antibodies
Rabbit
Clonality
All clonalities for EIF2A antibodies
Polyclonal
Conjugate
All conjugates for EIF2A antibodies
This EIF2A antibody is un-conjugated
Application
All applications for EIF2A antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Product Details anti-EIF2A Antibody
(hide)
Binding Specificity
All epitopes for EIF2A antibodies
pSer51
Purification
eIF2 alpha antibody was purified by immunoaffinity chromatography.
Immunogen
eIF2 alpha antibody was raised in Rabbit using the peptide sequence around phosphorylation site of Ser51 (E-L-S(p)-R-R) derived from Human eIF2A as the immunogen.
Alternatives
(show)
Application Details
(hide)
Application Notes
IF: 1:100-1:200, IHC: 1:50-1:100, WB: 1:500-1:1000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
Lot specific
Buffer
In liquid form PBS buffer (no MG2+ or Ca2+), pH 7.4, 150 mm NaCl, 0.02 % sodium azide and 50 % glycerol.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freeze/thaw cycles
Storage
-20 °C
Storage Comment
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
Target Details for EIF2A
(hide)
Target
EIF2A
(Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))
Alternative Name
eIF2 alpha
Pathways
Ribonucleoprotein Complex Subunit Organization , ER-Nucleus Signaling , Hepatitis C , Methionine Biosynthetic Process , Ribosome Assembly
Recently viewed
(hide)
Chat with us , powered by LiveChat